McElhaugh Michael J.

Track

Insider profile

McElhaugh Michael J.'s trades of Arbutus Biopharma Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
486.45
Quantity 56,377
Value US$1,913,151
Transaction date
Proposed sale
Price
483.38
Quantity 33,055
Value US$2,538,860
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-21 2025-04-21
PrS Proposed sale
56,377
486.45
US$1,913,151 		56,377 486.45 US$1,913,151
2025-04-15 2025-04-15
PrS Proposed sale
33,055
483.38
US$2,538,860 		33,055 483.38 US$2,538,860
2025-02-05 2025-02-04
PlS Planned sale
51,630 -48.6%
287.96
US$1,471,796 		51,630 -48.6% 287.96 US$1,471,796
2025-02-04 2025-02-04
PrS Proposed sale
23,790
3.28
US$78,103 		23,790 3.28 US$78,103
2024-02-05 2024-02-02
PlS Planned sale
10,164 -0.7%
2.31
US$23,504 		10,164 -0.7% 2.31 US$23,504
2021-02-10 2021-02-09
PlS Planned sale
20,000 -1.5%
5.00
US$100,000 		20,000 -1.5% 5.00 US$100,000
2020-12-16 2020-12-14
PlS Planned sale
10,000 -0.7%
5.00
US$50,032 		10,000 -0.7% 5.00 US$50,032
2020-12-16 2020-12-14
PlS Planned sale
30,000 -2.2%
5.00
US$150,000 		30,000 -2.2% 5.00 US$150,000
2020-07-27 2020-07-23
PlS Planned sale
20,000 -1.4%
5.01
US$100,200 		20,000 -1.4% 5.01 US$100,200